HBSAG SEROCOVERSION UNDER LAMIVUDINE IN HBEAG-NEGATIVE CHRONIC HEPATITIS B

被引：0
|
作者：
Seven, Gulseren
Idilman, Ramazan
Bozkus, Yusuf
Cinar, Kubilay
Kabacam, Gokhan
Yakut, Mustafa
Bozdayi, A. Mithat [1 ]
Yurdaydin, Cihan [1 ]
机构：
[1] Ankara Univ, Fac Med, Inst Hepatol, TR-06100 Ankara, Turkey
来源：
HEPATOLOGY | 2010年 / 52卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
453
引用
收藏
页码：545A / 546A
页数：2
相关论文
共 50 条
  • [1] Efficacy of lamivudine in HBeAg-negative chronic hepatitis B
    Rizzetto, M
    JOURNAL OF MEDICAL VIROLOGY, 2002, 66 (04) : 435 - 451
  • [2] HBsAg levels under interferon and lamivudine therapy in HBeAg-negative chronic hepatitis B (CHBe-) patients
    Manesis, EK
    Hadziyannis, ES
    Agelopoulou, OP
    Hadziyannis, S
    JOURNAL OF HEPATOLOGY, 2005, 42 : 185 - 185
  • [3] Extended lamivudine treatment in patients with HBeAg-negative chronic hepatitis B
    Rizzetto, M
    Tassopoulos, NC
    Goldin, RD
    Esteban, R
    Santantonio, T
    Heathcote, EJ
    Lagget, M
    Taak, NK
    Woessner, MA
    Gardner, SD
    JOURNAL OF HEPATOLOGY, 2005, 42 (02) : 173 - 179
  • [4] Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B
    Lai, CL
    Shouval, D
    Lok, AS
    Chang, TT
    Cheinquer, H
    Goodman, Z
    DeHertogh, D
    Wilber, R
    Zink, RC
    Cross, A
    Colonno, R
    Fernandes, L
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (10): : 1011 - 1020
  • [5] Predictors of HBsAg Seroclearance in HBeAg-Negative Chronic Hepatitis B Patients
    Kwak, Min-Sun
    Cho, Eun Ju
    Jang, Eun Sun
    Lee, Jeong-Hoon
    Yu, Su Jong
    Kim, Yoon Jun
    Yoon, Jung-Hwan
    Lee, Hyo-Suk
    DIGESTION, 2011, 84 : 23 - 28
  • [6] Role of hepatosteatosis in HBsAg seroconversion in HBeAg-negative chronic hepatitis B patients
    Bacaksiz, Ferhat
    Gokcan, Hale
    Akdogan, Meral
    Gokce, Dilara Turan
    Ari, Derya
    Gokbulut, Volkan
    Ergun, Yakup
    Ozturk, Omer
    Kacar, Sabite
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (12)
  • [7] Treatment of HBeAg-negative chronic hepatitis B
    Hadziyannis, SJ
    Papatheodoridis, GV
    Vassilopoulos, D
    SEMINARS IN LIVER DISEASE, 2003, 23 (01) : 81 - 88
  • [8] Clinical outcome of HBeAg-negative chronic hepatitis B in relation to virological response to lamivudine
    Di Marco, V
    Marzano, A
    Lampertico, P
    Andreone, P
    Santantonio, T
    Ahnasio, PL
    Rizzetto, M
    Craxì, A
    HEPATOLOGY, 2004, 40 (04) : 883 - 891
  • [9] Lamivudine treatment in HBeAg-negative chronic hepatitis B patients with low level viraemia
    Bozkaya, H
    Yurdaydin, C
    Idilman, R
    Tüzün, A
    Cinar, K
    Erkan, Ö
    Bozdayi, AM
    Erden, E
    Uzun, Y
    Cetinkaya, H
    Uzunalimoglu, Ö
    ANTIVIRAL THERAPY, 2005, 10 (02) : 319 - 325
  • [10] Quantitative HBsAg: Not helpful to evaluate fibrosis in HBeAg-negative chronic hepatitis B patients
    Loureiro, Dimitri
    Mansouri, Abdellah
    Asselah, Tarik
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2019, 25 (05): : 269 - 271
12345